These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 9008662

  • 21. Insulin-like growth factors augment steroid production and expression of steroidogenic enzymes in human fetal adrenal cortical cells: implications for adrenal androgen regulation.
    Mesiano S, Katz SL, Lee JY, Jaffe RB.
    J Clin Endocrinol Metab; 1997 May; 82(5):1390-6. PubMed ID: 9141522
    [Abstract] [Full Text] [Related]

  • 22. Changes in peripheral blood lymphocyte subsets in elderly subjects are associated with an impaired function of the hypothalamic-pituitary-adrenal axis.
    Martínez-Taboada V, Bartolomé MJ, Amado JA, Blanco R, García-Unzueta MT, Rodríguez-Valverde V, López-Hoyos M.
    Mech Ageing Dev; 2002 Sep; 123(11):1477-86. PubMed ID: 12425955
    [Abstract] [Full Text] [Related]

  • 23. Biotransformation of oral dehydroepiandrosterone in elderly men: significant increase in circulating estrogens.
    Arlt W, Haas J, Callies F, Reincke M, Hübler D, Oettel M, Ernst M, Schulte HM, Allolio B.
    J Clin Endocrinol Metab; 1999 Jun; 84(6):2170-6. PubMed ID: 10372727
    [Abstract] [Full Text] [Related]

  • 24. Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells.
    Arnold JT, Le H, McFann KK, Blackman MR.
    Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E573-84. PubMed ID: 15536203
    [Abstract] [Full Text] [Related]

  • 25. DHT and testosterone, but not DHEA or E2, differentially modulate IGF-I, IGFBP-2, and IGFBP-3 in human prostatic stromal cells.
    Le H, Arnold JT, McFann KK, Blackman MR.
    Am J Physiol Endocrinol Metab; 2006 May; 290(5):E952-60. PubMed ID: 16368782
    [Abstract] [Full Text] [Related]

  • 26. Dehydroepiandrosterone sulfate enhances natural killer cell cytotoxicity in humans via locally generated immunoreactive insulin-like growth factor I.
    Solerte SB, Fioravanti M, Vignati G, Giustina A, Cravello L, Ferrari E.
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3260-7. PubMed ID: 10487697
    [Abstract] [Full Text] [Related]

  • 27. Dehydroepiandrosterone supplementation in women with adrenal failure: impact on twenty-four hour GH secretion and IGF-related parameters.
    Christiansen JJ, Gravholt CH, Fisker S, Svenstrup B, Bennett P, Veldhuis J, Andersen M, Christiansen JS, Jørgensen JO.
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):461-9. PubMed ID: 15049961
    [Abstract] [Full Text] [Related]

  • 28. Endocrine effects of oral dehydroepiandrosterone in men with HIV infection: a prospective, randomized, double-blind, placebo-controlled trial.
    Poretsky L, Brillon DJ, Ferrando S, Chiu J, McElhiney M, Ferenczi A, Sison MC, Haller I, Rabkin J.
    Metabolism; 2006 Jul; 55(7):858-70. PubMed ID: 16784956
    [Abstract] [Full Text] [Related]

  • 29. Decreased release of the angiogenic peptide vascular endothelial growth factor in Alzheimer's disease: recovering effect with insulin and DHEA sulfate.
    Solerte SB, Ferrari E, Cuzzoni G, Locatelli E, Giustina A, Zamboni M, Schifino N, Rondanelli M, Gazzaruso C, Fioravanti M.
    Dement Geriatr Cogn Disord; 2005 Jul; 19(1):1-10. PubMed ID: 15383738
    [Abstract] [Full Text] [Related]

  • 30. Relationships of dehydroepiandrosterone sulfate in the elderly with functional, psychological, and mental status, and short-term mortality: a French community-based study.
    Berr C, Lafont S, Debuire B, Dartigues JF, Baulieu EE.
    Proc Natl Acad Sci U S A; 1996 Nov 12; 93(23):13410-5. PubMed ID: 8917605
    [Abstract] [Full Text] [Related]

  • 31. The role of interleukin 2 (IL-2) and serum-soluble IL-2 receptor cells in idiopathic IgA nephropathy.
    Parera M, Rivera F, Egido J, Campos A.
    Clin Immunol Immunopathol; 1992 May 12; 63(2):196-9. PubMed ID: 1351798
    [Abstract] [Full Text] [Related]

  • 32. Dehydroepiandrosterone supplementation and bone turnover in middle-aged to elderly men.
    Kahn AJ, Halloran B, Wolkowitz O, Brizendine L.
    J Clin Endocrinol Metab; 2002 Apr 12; 87(4):1544-9. PubMed ID: 11932279
    [Abstract] [Full Text] [Related]

  • 33. Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge Study to a sociobiomedical issue.
    Baulieu EE, Thomas G, Legrain S, Lahlou N, Roger M, Debuire B, Faucounau V, Girard L, Hervy MP, Latour F, Leaud MC, Mokrane A, Pitti-Ferrandi H, Trivalle C, de Lacharrière O, Nouveau S, Rakoto-Arison B, Souberbielle JC, Raison J, Le Bouc Y, Raynaud A, Girerd X, Forette F.
    Proc Natl Acad Sci U S A; 2000 Apr 11; 97(8):4279-84. PubMed ID: 10760294
    [Abstract] [Full Text] [Related]

  • 34. The influence of age and gender on serum dehydroepiandrosterone sulphate (DHEA-S), IL-6, IL-6 soluble receptor (IL-6 sR) and transforming growth factor beta 1 (TGF-beta1) levels in normal healthy blood donors.
    Young DG, Skibinski G, Mason JI, James K.
    Clin Exp Immunol; 1999 Sep 11; 117(3):476-81. PubMed ID: 10469050
    [Abstract] [Full Text] [Related]

  • 35. Long-term low-dose oral administration of dehydroepiandrosterone modulates adrenal response to adrenocorticotropic hormone in early and late postmenopausal women.
    Genazzani AR, Pluchino N, Begliuomini S, Stomati M, Bernardi F, Pieri M, Casarosa E, Palumbo M, Genazzani AD, Luisi M.
    Gynecol Endocrinol; 2006 Nov 11; 22(11):627-35. PubMed ID: 17145649
    [Abstract] [Full Text] [Related]

  • 36. Age-related changes of neuro-endocrine-immune interactions in healthy humans.
    Mazzoccoli G, Correra M, Bianco G, De Cata A, Balzanelli M, Giuliani A, Tarquini R.
    J Biol Regul Homeost Agents; 1997 Nov 11; 11(4):143-7. PubMed ID: 9582614
    [Abstract] [Full Text] [Related]

  • 37. Effects of dehydroepiandrosterone (DHEA) supplementation on hormonal, metabolic and behavioral status in patients with hypoadrenalism.
    Libè R, Barbetta L, Dall'Asta C, Salvaggio F, Gala C, Beck-Peccoz P, Ambrosi B.
    J Endocrinol Invest; 2004 Sep 11; 27(8):736-41. PubMed ID: 15636426
    [Abstract] [Full Text] [Related]

  • 38. Unequal impact of short-term testosterone repletion on the somatotropic axis of young and older men.
    Gentili A, Mulligan T, Godschalk M, Clore J, Patrie J, Iranmanesh A, Veldhuis JD.
    J Clin Endocrinol Metab; 2002 Feb 11; 87(2):825-34. PubMed ID: 11836328
    [Abstract] [Full Text] [Related]

  • 39. IL-6, DHEA and the ageing process.
    James K, Premchand N, Skibinska A, Skibinski G, Nicol M, Mason JI.
    Mech Ageing Dev; 1997 Feb 11; 93(1-3):15-24. PubMed ID: 9089567
    [Abstract] [Full Text] [Related]

  • 40. Increases in bone mineral density in response to oral dehydroepiandrosterone replacement in older adults appear to be mediated by serum estrogens.
    Jankowski CM, Gozansky WS, Kittelson JM, Van Pelt RE, Schwartz RS, Kohrt WM.
    J Clin Endocrinol Metab; 2008 Dec 11; 93(12):4767-73. PubMed ID: 18812486
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.